The contribution of histone deacetylases (HDACs) in the regulation of histone and non-histone proteins: Implications for fibrotic diseases |
Sunyoung Jang1 (Graduate student), Nayun Choi1 (Graduate student), Jong Hoon Park 2 (Professor), Kyung Hyun Yoo 1,3,* (Professor) |
1Laboratory of biomedical genomics, Department of Biological Sciences and 2Molecular medicine lab, Department of Biological Sciences and 3Research Institute of Women’s Health, Sookmyung Women’s University |
Abstract
Histone deacetylases (HDACs) are critical regulators of both histone and non-histone proteins, influencing various cellular processes, including gene expression, cell proliferation, and fibrosis. This review provides a comprehensive analysis of the role of HDACs in fibrotic diseases affecting multiple organs, including the liver, kidney, heart, lung, and colon. We discuss the distinct contributions of different HDAC classes and the mechanisms by which they promote fibrosis, highlighting both histone-dependent and independent pathways. Furthermore, we summarize current advances in the development of HDAC inhibitors and their potential as therapeutic agents for fibrosis. Ongoing clinical trials targeting HDACs in fibrotic diseases are also reviewed, underscoring the translational relevance of preclinical findings. Finally, we propose future research directions, emphasizing the need for selective HDAC inhibitors and combination therapies that may enhance therapeutic efficacy and reduce side effects. This review aims to provide a solid foundation for future research and clinical applications of HDAC inhibitors in fibrosis treatment.
|
Abstract, Accepted Manuscript [Submitted on July 31, 2024, Accepted on September 21, 2024] |
|